期刊文献+

解郁膏联合托瑞米芬治疗气滞血瘀痰凝型乳腺增生症的临床效果 预览

Clinical effect of Jieyu Ointment combined with Toremifene treating cyclomastopathy due to qi stagnation,blood stasis and phlegm congealing
在线阅读 下载PDF
收藏 分享 导出
摘要 目的研究解郁膏联合托瑞米芬治疗气滞血瘀痰凝型乳腺增生症的临床效果。方法选择我院2016年11月~2017年7月收治的120例气滞血瘀痰凝型乳腺增生症患者,按照随机数字表法分为两组,每组各60例,研究组采用解郁膏结合托瑞米芬治疗,对照组仅采用托瑞米芬。比较两组的临床效果。结果研究组的总有效率为93.33%,高于对照组的81.67%(P〈0.05)。治疗前,两组的乳房疼痛、乳房肿块大小、肿块质地评分比较,差异均无统计学意义(P〉0.05);治疗后,两组的上述评分均明显低于治疗前,且两组的上述评分比较,差异有统计学意义(P〈0.05)。研究组的不良反应总发生率为5.00%,低于对照组的15.00%,复发率为3.33%,低于对照组的13.33%,差异有统计学意义(P〈0.05)。结论解郁膏联合托瑞米芬治疗气滞血瘀痰凝型乳腺增生症的临床效果更好,可有效缓解疼痛,改善肿块大小以及质地,促进病情快速恢复,避免复发,安全性高。 Objective To study the clinical effect of Jieyu Ointment combined with Toremifene treating cyclomastopathy due to qi stagnation,blood stasis and phlegm congealing. Methods One hundred and twenty patients with cyclomastopathy due to qi stagnation,blood stasis and phlegm congealing admitted into our hospital from November 2016 to July2017 were selected and they were divided into the two groups according to the random number table method,and there were 60 cases in each group. The study group was treated with Jieyu Ointment combined with Toremifene, while in the control group, only Toremifene was adopted. The clinical effect between the two groups was comapred. Results The total effectiveness rate of the study group was 93.33%,which was higher than that of the control group accounting(81.67%)(P〈0.05). There was no significant difference in the scores of breast pain,the size of mass,and the texture of mass between the two groups before the treatment(P〉 0.05). After treatment,the above-mentioned scores in the two groups were obviously lower than those before,and there was a statistical difference of the above-mentioned scores between the two groups(P〈0.05). The total incidence of adverse reactions in the study group was 5.00%, which was lower than that of the control group accounting(15.00%) and the recurrence rate of the study group was 3.33%, which lower than that in the control group(13.33%), and the differences were statistically significant(P〈0.05). Conclusion The clinical effect of Jieyu Ointment combined with Toremifene treating cyclomastopathy due to qi stagnation,blood stasis and phlegm congealing is better,and it can effectively relieve pain, improve the size and texture of the tumor, promote the rapid recovery of the disease, avoid recurrence and have high safety.
作者 王芳 李娟 赵树文 甘国兴 WANG Fang Ll Juan ZHAO Shu-wen GAN Guo-xing( Department of General Surgery, Traditional Chinese Medicine Hospital of Qingyuan City, Guangdong Province, Qingyuan 511500,China)
出处 《中国当代医药》 2018年第20期137-139,共3页 China Modern Medicine
基金 广东省清远市医疗卫生领域自筹经费科技计划项目(2016B063)
关键词 临床疗效 解郁膏 乳腺增生症 托瑞米芬 Clinical effect Jieyu Ointment Cyclomastopathy Toremifene
  • 相关文献

参考文献14

二级参考文献87

  • 1汪丽杰,周洪妹,丁敬远,包伟忠,孙静,谢琦.乳癖消联用逍遥丸治疗乳腺增生病725例[J].河南中医,2005,25(4):72-72. 被引量:3
  • 2徐雪松,黄雁萍,邹士林.托瑞米芬治疗乳腺囊性增生症临床疗效的初步观察[J].肿瘤防治杂志,2005,12(4):305-306. 被引量:4
  • 3陈华元,郑陆.乳癖消片择期给药治疗乳腺增生病60例[J].南京中医药大报,1998,14(2) :22. 被引量:1
  • 4倪青.,钱丽旗.乳腺增生与乳腺癌合理用药249问[M].北京:中国医药科技出版社,2009:9-11. 被引量:1
  • 5张雅娟,蔡春茹,陈尔英,等.自制中药贴配合理疗仪治疗乳腺增生症疗效分析[J].中国中医药信息杂志,2012,19(6):64. 被引量:2
  • 6Young C D,Pfefferle A D,Owens P,et al.Conditional loss of Erb B3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency,gene expression,or signaling[J].Cancer Res,2013,73(13):4075-4085. 被引量:1
  • 7Best S A,Hutt K J,Fu N Y,et al.Dual roles for Id4 in the regulation of estrogen signaling in the mammary gland and ovary[J].Development,2014,141(16):3159-3164. 被引量:1
  • 8Vogel C L,Johnston M A,Capers C,et al.Toremifene for breast cancer:a review of 20 years of data[J].Clin Breast Cancer,2014,14(1):1-9. 被引量:1
  • 9Douglas N C,Papaioannou V E.The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer[J].J Mammary Gland Biol Neoplasia,2013,18(2):143-147. 被引量:1
  • 10Cortez V,Samayoa C,Zamora A,et al.PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma[J].Cancer Res,2014,74(24):7395-7405. 被引量:1

共引文献26

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈
新型冠状病毒肺炎防控与诊疗专栏